Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Supply of generic and biosimilar transition medicines to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Accord Healthcare Ltd | 04596349 | ~£218,806,983 estimated from lot values | 7 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Apremilast · Nintedanib · Cancer Medicines (Group 1) · Cancer Medicines (Group 2) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Amarox Limited | 10997632 | ~£126,134,100 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Amgen Ltd | 02354269 | ~£121,209,329 estimated from lot values | 2 lots Cancer Medicines (Group 2) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| AOP Orphan Ltd | 08082765 | ~£126,134,100 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Biocon Pharma UK Ltd | 11716196 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | - |
| Brown and Burk | - | ~£100,468,848 estimated from lot values | 3 lots Cardiovascular and Respiratory Medicines · Psychiatry and Neurology Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Celix Pharma Ltd. | 12474195 | ~£155,410,038 estimated from lot values | 5 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Apremilast · Cardiovascular and Respiratory Medicines · Nintedanib · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£264,224,095 estimated from lot values | 4 lots Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) · Cytokine Modulators (Omalizumab) · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) | - |
| Chiesi Limited | 02140985 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | LOBBYIST Ovid Consulting Ltd (7 quarters) Hill & Knowlton Limited (4 quarters) Portland PR Limited (2 quarters) |
| CST Pharma Ltd | 04212740 | ~£457,484 estimated from lot values | 1 lot Cardiovascular and Respiratory Medicines | - |
| Dr Falk Pharma UK Ltd | 02307698 | ~£126,134,100 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Dr Reddy's Laboratories (UK) Ltd | 01729064 | ~£102,185,203 estimated from lot values | 4 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Nintedanib · Cancer Medicines (Group 2) | - |
| Ferring Pharmaceuticals Limited | 01198007 | ~£141,309,345 estimated from lot values | 3 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cancer Medicines (Group 1) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | DONOR£1.44M across 11 donations To: Liberal Democrats |
| Fresenius Kabi Ltd | 02182135 | ~£148,629,761 estimated from lot values | 3 lots Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) | - |
| Gedeon Richter UK Ltd | 04325685 | ~£148,629,761 estimated from lot values | 3 lots Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Glenmark Pharmaceuticals Europe Ltd | 05040260 | ~£141,309,345 estimated from lot values | 3 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cancer Medicines (Group 1) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Janssen-Cilag Ltd | 01027904 | ~£199,901,154 estimated from lot values | 1 lot Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Lupin Healthcare UK Ltd | 06925119 | ~£100,011,364 estimated from lot values | 2 lots Psychiatry and Neurology Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Mercury Pharma Group | 02330913 | ~£99,950,577 estimated from lot values | 1 lot Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Mercury Pharmaceuticals Limited | 02619880 | ~£190,359,105 estimated from lot values | 5 lots Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) · Cytokine Modulators (Omalizumab) · Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Nintedanib · Cancer Medicines (Group 2) | - |
| MSN Labs | - | ~£126,134,100 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Perennial Pharma Ltd | 11826246 | ~£126,134,100 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Pfizer | 00526209 | ~£115,125,822 estimated from lot values | 2 lots Cancer Medicines (Group 1) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Roche Products Ltd | 00100674 | ~£199,901,154 estimated from lot values | 1 lot Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Samsung Bioepis Ltd | 08840722 | ~£148,629,761 estimated from lot values | 3 lots Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Sandoz | 01547204 | ~£148,629,761 estimated from lot values | 3 lots Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| SERB SA | - | ~£126,134,100 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| STADA UK - Thornton & Ross | - | ~£191,941,971 estimated from lot values | 7 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Apremilast · Cardiovascular and Respiratory Medicines · Cancer Medicines (Group 1) · Cancer Medicines (Group 2) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Takeda UK Limited | 03362860 | ~£126,134,100 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | LOBBYIST Hill & Knowlton Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (2 quarters) Burkitt Communications Ltd (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
| Teva UK Ltd | 00302461 | ~£198,005,715 estimated from lot values | 7 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Apremilast · Cardiovascular and Respiratory Medicines · Nintedanib · Cancer Medicines (Group 1) · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Theramex HQ UK Ltd | 10944626 | ~£99,950,577 estimated from lot values | 1 lot Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Viatris UK Healthcare Ltd | 09189103 | ~£126,134,100 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | LOBBYIST Instinctif Partners Holdings Limited (1 quarter) |
| Vifor Pharma UK Limited | 06514784 | ~£127,371,009 estimated from lot values | 2 lots Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Wockhardt UK Limited | 05835570 | ~£53,506,019 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Nintedanib | - |
| Zentiva UK | - | ~£64,311,913 estimated from lot values | 4 lots Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cardiovascular and Respiratory Medicines · Cancer Medicines (Group 1) · Cancer Medicines (Group 2) | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£99,950,577 estimated from lot values | 1 lot Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
| Zydus Pharmaceuticals UK Ltd | 14646636 | ~£126,591,584 estimated from lot values | 3 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cardiovascular and Respiratory Medicines · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 10 lots, each awarded separately. 420 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 8 Cancer Medicines (Group 1) Feb 2026 – Jan 2027 | £15,175,245 £1,925,364 initial term | 42 | Accord Healthcare Ltd Ferring Pharmaceuticals Limited Glenmark Pharmaceuticals Europe Ltd Teva UK Ltd STADA UK - Thornton & Ross Zentiva UK Pfizer | active |
| Lot 1 Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) Feb 2026 – Feb 2027 | £99,950,577 £90,643,012 initial term | 42 | Mercury Pharmaceuticals Limited Celltrion Healthcare United Kingdom Limited Fresenius Kabi Ltd Roche Products Ltd Janssen-Cilag Ltd Brown and Burk Lupin Healthcare UK Ltd Accord Healthcare Ltd Amarox Limited Amgen Ltd AOP Orphan Ltd Celix Pharma Ltd. Chiesi Ltd Dr Falk Pharma UK Ltd Ferring Pharmaceuticals Limited Fresenius Kabi Gedeon Richter UK Ltd Glenmark Pharmaceuticals Europe Ltd Mercury Pharma Group MSN Labs Perennial Pharma Ltd Pfizer Samsung Bioepis Ltd Sandoz SERB SA Takeda UK Limited Teva UK Ltd Theramex HQ UK Ltd STADA UK - Thornton & Ross Viatris UK Healthcare Ltd Vifor Pharma UK Limited Zentiva Pharma UK Ltd Zydus Pharmaceuticals UK Ltd | active |
| Lot 2 Cytokine Modulators (Omalizumab) Apr 2026 – Feb 2027 | £15,643,757 £9,253,091 initial term | 42 | Mercury Pharmaceuticals Limited Celltrion Healthcare United Kingdom Limited | active |
| Lot 3 Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines Feb 2026 – Jul 2027 | £26,183,523 £3,594,493 initial term | 42 | Mercury Pharmaceuticals Limited Accord Healthcare Ltd Amarox Limited AOP Orphan Ltd Biocon Pharma UK Ltd Celix Pharma Ltd. Chiesi Limited Dr Falk Pharma UK Ltd Dr Reddy's Laboratories (UK) Ltd Ferring Pharmaceuticals Limited Glenmark Pharmaceuticals Europe Ltd MSN Labs Perennial Pharma Ltd SERB SA Takeda UK Limited Teva UK Ltd STADA UK - Thornton & Ross Viatris UK Healthcare Ltd Wockhardt UK Limited Zydus Pharmaceuticals UK Ltd | active |
| Lot 4 Denosumab (Osteoporosis) and Ferric Carboxymaltose Feb 2026 – Jul 2027 | £27,420,432 £2,254,091 initial term | 42 | Celltrion Healthcare United Kingdom Limited Fresenius Kabi Ltd Accord Healthcare Ltd Dr Reddy's Laboratories (UK) Ltd Teva UK Ltd STADA UK - Thornton & Ross Zentiva UK Gedeon Richter UK Ltd Samsung Bioepis Ltd Sandoz Vifor Pharma UK Limited | active |
| Lot 5 Apremilast Feb 2026 – Oct 2027 | £1,495,958 £663,520 initial term | 42 | Accord Healthcare Ltd Celix Pharma Ltd. Teva UK Ltd STADA UK - Thornton & Ross | active |
| Lot 6 Cardiovascular and Respiratory Medicines Feb 2026 – May 2028 | £457,484 £78,009 initial term | 42 | Brown and Burk Celix Pharma Ltd. Teva UK Ltd STADA UK - Thornton & Ross Zentiva UK Zydus Pharmaceuticals UK Ltd CST Pharma Ltd | active |
| Lot 7 Nintedanib Apr 2026 – May 2028 | £27,322,496 £1,400,387 initial term | 42 | Celix Pharma Ltd. Dr Reddy's Laboratories (UK) Ltd Teva UK Ltd Wockhardt UK Limited Accord Healthcare Ltd Mercury Pharmaceuticals Limited | active |
| Lot 9 Cancer Medicines (Group 2) Feb 2026 – Jan 2027 | £21,258,752 £18,207,081 initial term | 42 | Mercury Pharmaceuticals Limited Celltrion Healthcare United Kingdom Limited Fresenius Kabi Ltd Accord Healthcare Ltd Dr Reddy's Laboratories (UK) Ltd STADA UK - Thornton & Ross Zentiva UK Gedeon Richter UK Ltd Samsung Bioepis Ltd Sandoz Amgen Ltd | active |
| Lot 10 Psychiatry and Neurology Medicines Feb 2026 – Sept 2028 | £60,787 £188,432 initial term | 42 | Brown and Burk Lupin Healthcare UK Ltd | active |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £634,269,431 in 7,471 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS Supply Chain (DHSC-funded), NHS England, Manchester University NHS Foundation Trust and 20 more public bodies (2010-04-28 to 2026-03-31).
Changes the buyer published to this notice after it first appeared.
1) Invitation to Tender published later than expected. Adjustment to deadline to meet minimum timescale requirement.
2) Lot 7 start date changed to avoid originator marketing exclusivity infringement.
Published by the buyer on this notice. Check the original notice — details change and are not updated here.